We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wrist Access Found Suitable for Carotid Stenting

By HospiMedica International staff writers
Posted on 27 Dec 2012
A new study shows that wrist access for carotid artery stenting (CAS) can have excellent outcomes for patients with peripheral vascular disease and other factors that make conventional femoral access more risky.

Researchers at Wake Heart and Vascular Associates (Raleigh, NC, USA) conducted a retrospective analysis of 382 patients (mean age 68, 70% male) who had undergone transradial (TR) CAS at two centers. More...
Demographics, the technique used to deploy the sheath in the common carotid, procedural details, results, and complications were evaluated. The results showed that total CAS was successful in 91% patients; 93% right CA, 88% in bovine left CA, and 88% in left CA. The specific technique varied with the anatomy.

Seven different carotid artery stents and seven different distal embolic protection devices were used. Adverse events included two major strokes (0.6%) one of whom died, three minor strokes (1%), and no myocardial infarction (MI) at 30 days. No bleeding complications occurred, although 6% of the patients had asymptomatic postprocedure radial occlusion. Inadequate catheter support at origin of the common carotid artery (CCA) was the technical cause of failure in the unsuccessful cases, which were then completed from femoral access as part of the same procedure.

“The low incidence of periprocedural death, stroke, and myocardial infarction was comparable with other large studies of carotid stenting from femoral access and/or endarterectomy,” concluded lead author Tift Mann, MD, and colleagues. “The transradial approach is an alternative for carotid artery stenting in the presence of factors that increase the risk or difficulty of femoral access.”

CAS is an alternative to carotid endarterectomy (CEA) for revascularization of the internal carotid artery. CAS from the femoral approach may be problematic due to peripheral vascular disease, anatomical variations of the aortic arch, and access site complications. The TR approach may cut down on catheter contact with the aortic arch, which is the source of emboli typically responsible for procedure-related stroke.

Related Links:
Wake Heart and Vascular Associates



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.